Hospitals

LevelJump Healthcare Corp. Announces Update on Alberta Acquisitions and Preferred Share Unit Offering

Toronto, Ontario--(Newsfile Corp. - September 14, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the…

10 months ago

Survey: Chief Nursing Officers View Virtual Nursing as Integral to Care

Improved nurse satisfaction and retention cited by CNOs as top reason to implement virtual nursing solutions, AvaSure-Joslin Insight survey reveals…

10 months ago

MSSP ACOs on the Innovaccer Platform Generated 47.5% Greater Savings, $370 Million Cumulative in PY 2022

Seventh consecutive year that Innovaccer's customers excelled as high-performing ACOs SAN FRANCISCO, Sept. 14, 2023 /PRNewswire/ -- Today, Innovaccer, the healthcare…

10 months ago

Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting…

10 months ago

Fujitsu and Baptist Health South Florida transform operating room scheduling with newly launched solution to boost utilization rates and the financial health of the surgical discipline

Recent trials with the solution delivered 37% improvement in available prime-time minutes over a three-month period TOKYO, Sept. 14, 2023…

10 months ago

Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics

Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of…

10 months ago

ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences

Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and Safety of ProSomnus Precision Devices for…

10 months ago

Landos Biopharma Announces Strategic Research Collaboration with KU Leuven and University Hospitals Leuven to Further Characterize the Effects of NX-13 on Epithelial Cells

Collaboration Will Focus on Defining the Effects Of NX-13 in Ulcerative Colitis Patient Derived Organoid ModelsNEW YORK, Sept. 14, 2023…

10 months ago

Anavex’s Phase 2b/3 Trial of Blarcamesine (ANAVEX®2-73) in Patients with Alzheimer’s Disease Shows Robust Clinical Efficacy and Slows Neurodegeneration

Significant Reduction of Amyloid Beta Biomarkers of Alzheimer’s PathologyNEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.…

10 months ago

AlveoGene Launches to Develop Unique Inhaled Gene Therapies for Rare Respiratory Disorders

New gene therapy company created and funded by Oxford Science Enterprises, Harrington Discovery Institute and Old College Capital in partnership…

10 months ago